Expression of COX-2, Ki-67, cyclin D1, and p21 in endometrial endometrioid carcinomas

International Journal of Gynecological Pathology

Volumn 21, Issue 2, 2002, Pages 147-154

  Cao, Q Jackie ^a   Einstein, Mark H ^a   Anderson, Patrick S ^a   Runowicz, Carolyn D ^a   Balan, Raluca ^a   Jones, Joan G ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

COX 2; Cyclin D1; Endometrioid carcinoma; Endometrium; Ki 67; p21

Indexed keywords

CYCLIN D1; CYCLOOXYGENASE 2; GENE PRODUCT; KI 67 ANTIGEN; NONSTEROID ANTIINFLAMMATORY AGENT; PROTEIN P21;

ARTICLE; BENIGN TUMOR; CARCINOGENESIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; ENDOMETRIUM CARCINOMA; ENDOMETRIUM HYPERPLASIA; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR DIFFERENTIATION; TUMOR GROWTH;

EID: 0036203143     PISSN: 02771691     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004347-200204000-00007     Document Type: Article

References (28)

1. COX-2 inhibitors
2. The role of cyclooxygenases in inflammation, cancer, and development
3. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas
4. High cyclooxygenase-2 expression in stage IB cervical cancer with lymph node metastasis or parametrial invasion
5. Expression of cyclooxygenase-1 and -2 in human colorectal cancer
6. Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck
7. Expression of cyclooxygenase-2 (COX-2) in human invasive transitional cell carcinoma (TCC) of the urinary bladder
8. Expression of cyclooxygenase-2 in human gastric carcinoma
9. Sulindac causes regression of rectal polyps in familial adenomatous polyposis
10. Randomized controlled trial of the effect of sulindac on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis
11. Expression of cyclooxygenase 2 by prostaglandin E(2) in human endometrial adenocarcinoma cell line HEC-1B
12. Aspirin effects on endometrial cancer cell growth
13. p27 and cyclin D1 abnormalities in uterine papillary serous carcinoma
14. Immunohistochemical localization of p21 (WAF1/CIP1) in normal, hyperplastic, and neoplastic uterine tissues
15. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis
16. Expression of cyclooxygenase-2 in human hepatocellular carcinoma: Relevance to tumor dedifferentiation
17. Increased expression of COX-2 in nontumor liver tissue is associated with shorter disease-free survival in patients with hepatocellular carcinoma
18. Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer
19. Perspective defects in cell cycle control and cancer
20. p53, through p21 (WAF1/CIP1), induces cyclin D1 synthesis
21. Cyclins and cancer. II Cyclin D and CDK inhibitors come of age
22. Overexpression of p21WAF1/CIP1 and MDM2 characterizes serous borderline ovarian tumors
23. G1 phase progression: Cycling on cue
24. Topological control of p21WAF1/CIP1 expression in normal and neoplastic tissues
25. Characterization of a panel of novel anti-p21Waf1/Cip1 monoclonal antibodies and immunochemical analysis of p21Waf1/Cip1 expression in normal human tissues
26. Prognostic significance of angiogenesis and Ki-67, p53, and p21 expression: A population-based endometrial carcinoma study
27. High level expression of p27(kip1) and cyclin D1 in some human breast cancer cells: Inverse correlation between the expression of p27(kip1) and degree of malignancy in human breast and colorectal cancers
28. p21WAF1/CIP1 mutants deficient in inhibiting cyclin-dependent kinases (CDKs) can promote assembly of active cyclin D/CDK4(6) complexes in human tumor cells